Molecular Partners Ag (MOLN) Return on Equity (2022 - 2025)
Historic Return on Equity for Molecular Partners Ag (MOLN) over the last 4 years, with Q3 2025 value amounting to 121199.7%.
- Molecular Partners Ag's Return on Equity fell 1211994900.0% to 121199.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 121199.7%, marking a year-over-year decrease of 1211994900.0%. This contributed to the annual value of 341.38% for FY2024, which is 259100.0% down from last year.
- Latest data reveals that Molecular Partners Ag reported Return on Equity of 121199.7% as of Q3 2025, which was down 1211994900.0% from 95.47% recorded in Q2 2025.
- In the past 5 years, Molecular Partners Ag's Return on Equity ranged from a high of 1108074.46% in Q1 2022 and a low of 121199.7% during Q3 2025
- For the 4-year period, Molecular Partners Ag's Return on Equity averaged around 109707.21%, with its median value being 0.93% (2023).
- Per our database at Business Quant, Molecular Partners Ag's Return on Equity tumbled by 2000000000bps in 2023 and then skyrocketed by 956700bps in 2025.
- Molecular Partners Ag's Return on Equity (Quarter) stood at 655377.82% in 2022, then crashed by -100bps to 76.45% in 2023, then surged by 32bps to 52.36% in 2024, then crashed by -231392bps to 121199.7% in 2025.
- Its last three reported values are 121199.7% in Q3 2025, 95.47% for Q2 2025, and 55.34% during Q1 2025.